The present invention provides a 7-chloro-6-(2,2,2-trifluoroethylamino)-2,3,4,5-tetrahydro-1H-benzo[d]azepine of formula (I): or a pharmaceutically acceptable salt thereof, and its use as a selective 5-HT2c agonist for the treatment of 5-HT2c associated disorders including obesity, obsessive/compulsive disorder, anxiety, and depression.
本发明提供了一种式(I)的7-
氯-6-(
2,2,2-三氟乙基氨基)-2,3,4,5-四氢-1H-苯并[d]氮杂
环己烯,或其药学上可接受的盐,并且其用作选择性5-HT2c激动剂,用于治疗与5-HT2c相关的疾病,包括肥胖症、强迫/强迫症、焦虑和抑郁症。